HLA Alleles are Genetic Markers for Susceptibility and Resistance towards Leprosy in a Mexican Mestizo Population
暂无分享,去创建一个
J. Granados | J. Rangel-Moreno | S. Khader | I. Estrada-García | G. Sanchez-Schmitz | S. Estrada-Parra | M. Aguilar-Medina | Mónica Escamilla-Tilch | Luis O Frías-Castro | Geovanni Romero-Quintana | Eliakym Arámbula Meraz | R. Ramos-Payán | E. Arámbula Meraz
[1] Yong-Gang Yao,et al. Fine mapping of the GWAS loci identifies SLC35D1 and IL23R as potential risk genes for leprosy. , 2016, Journal of dermatological science.
[2] F. C. de Souza-Santana,et al. Human leukocyte antigen class I and class II alleles are associated with susceptibility and resistance in borderline leprosy patients from Southeast Brazil , 2015, BMC Infectious Diseases.
[3] Christopher R. Gignoux,et al. The genetics of Mexico recapitulates Native American substructure and affects biomedical traits , 2014, Science.
[4] J. Granados,et al. Association of genetic polymorphism of HLA-DRB1 antigens with the susceptibility to lepromatous leprosy. , 2013, Biomedical reports.
[5] P. Fine,et al. Patterns and trends of leprosy in Mexico: 1989-2009. , 2012, Leprosy review.
[6] Liangdan Sun,et al. Identification of two new loci at IL23R and RAB32 that influence susceptibility to leprosy , 2011, Nature Genetics.
[7] L. Abel,et al. Leprosy as a genetic disease , 2011, Mammalian Genome.
[8] T. Hawn,et al. Leprosy and the Human Genome , 2010, Microbiology and Molecular Biology Reviews.
[9] D. Malhotra,et al. Leprosy and the Adaptation of Human Toll-Like Receptor 1 , 2010, PLoS pathogens.
[10] Ying Wang,et al. Genomewide association study of leprosy. , 2009, The New England journal of medicine.
[11] D. Scollard. The biology of nerve injury in leprosy. , 2008, Leprosy review.
[12] Karina Marinic,et al. Papel de las moléculas HLA-DR y HLA-DQ en la lepra multibacilar y paucibacilar en la provincia del Chaco; Argentina , 2007 .
[13] Meenakshi Singh,et al. Stepwise replication identifies a low-producing lymphotoxin-α allele as a major risk factor for early-onset leprosy , 2007, Nature Genetics.
[14] L. Abel,et al. Genetic predisposition to leprosy: A major gene reveals novel pathways of immunity to Mycobacterium leprae. , 2006, Seminars in immunology.
[15] T. Ottenhoff,et al. HLA and leprosy in the pre and postgenomic eras. , 2006, Human immunology.
[16] Diana J L Williams,et al. The Continuing Challenges of Leprosy , 2006, Clinical Microbiology Reviews.
[17] M. Mira. Genetic host resistance and susceptibility to leprosy. , 2006, Microbes and infection.
[18] J. Casanova,et al. Genetic dissection of immunity in leprosy. , 2005, Current opinion in immunology.
[19] F. Vargas‐Ocampo,et al. Analysis of 6000 skin biopsies of the national leprosy control program in Mexico. , 2004, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.
[20] U. Shankarkumar. HLA associations in leprosy patients from Mumbai, India. , 2004, Leprosy review.
[21] T. Hudson,et al. Susceptibility to leprosy is associated with PARK2 and PACRG , 2004, Nature.
[22] D. Mohanty,et al. Novel HLA Class I Alleles Associated with Indian Leprosy Patients , 2003, Journal of biomedicine & biotechnology.
[23] T. Hudson,et al. Chromosome 6q25 is linked to susceptibility to leprosy in a Vietnamese population , 2003, Nature Genetics.
[24] R. Pitchappan,et al. A major susceptibility locus for leprosy in India maps to chromosome 10p13 , 2001, Nature Genetics.
[25] T. Ottenhoff,et al. Definition of a human suppressor T-cell epitope. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[26] Piero Carninci,et al. A fast method for high-quality genomic DNA extraction from whole human blood. , 1991, BioTechniques.
[27] T. Ottenhoff,et al. HLA‐DQ molecules and the control of Mycobacterium leprae‐specific T cell nonresponsiveness in lepromatous leprosy patients , 1990, European journal of immunology.
[28] C. Gorodezky,et al. Tuberculoid leprosy in Mexicans is associated with HLA-DR3. , 1987, Leprosy review.
[29] T. Ottenhoff,et al. HLA class II immune response and suppression genes in leprosy. , 1987, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.
[30] P. Terasaki,et al. Histocompatibility antigens in patients with leprosy. , 1976, The Journal of infectious diseases.
[31] D P Byar,et al. How many controls? , 1976, Journal of chronic diseases.
[32] C. Gorodezky,et al. Distribution of Some of the HL‐A System Lymphocyte Antigens in Mexicans , 1972, Vox sanguinis.
[33] B. Woolf. ON ESTIMATING THE RELATION BETWEEN BLOOD GROUP AND DISEASE , 1955, Annals of human genetics.
[34] M. Mira,et al. Genetics of leprosy: Expected-and unexpected-developments and perspectives. , 2016, Clinics in dermatology.
[35] M. Mira,et al. Genetics of leprosy: expected and unexpected developments and perspectives. , 2015, Clinics in dermatology.
[36] M. L. Molinari,et al. [Role of HLA-DR and HLA-DQ alleles in multibacillary leprosy and paucibacillary leprosy in the province of Chaco (Argentina)]. , 2007, Enfermedades infecciosas y microbiologia clinica.
[37] C. Gorodezky,et al. Molecular mechanisms of MHC linked susceptibility in leprosy: towards the development of synthetic vaccines. , 2004, Tuberculosis.
[38] J. Casanova,et al. The human model: a genetic dissection of immunity to infection in natural conditions , 2004, Nature Reviews Immunology.
[39] A. Hill,et al. The immunogenetics of human infectious diseases. , 1998, Annual review of immunology.
[40] H GRUNEBERG,et al. Human genetics. , 1947, The Eugenics review.